The doc social Morning Brief is a short daily briefing on the news that actually changes how surgeons and the people who support them work: reimbursement and policy, device clearances and recalls, guideline changes, and the commercial shifts behind them.
It is written for an audience that already knows the clinical fundamentals, so it skips the explainer and goes to what is new — where a device sits against what already exists, what a rule change does to a real clinic day, and what is worth doing about it this week.
Produced by doc social. Narration is synthesized; the reporting and editorial judgement are ours, and every story is sourced.
Episodes
33 total · newest first
Press play on any episode and the show keeps running from there.
FDA approves two-level use of Centinel Spine's prodisc C Nova, making three of Centinel's four cervical discs labeled for one or two contiguous levels · Zimmer Biomet and THINK Surgical sign a multi-year extension of their exclusive distribution deal for a Persona-compatible version of the TMINI handheld knee robot · Patient-specific spine at NASS: Carlsmed starts the full U.S. launch of its aprevo lumbar bi-lateral posterior system as Globus previews its FDA-cleared SCRIPT patient-specific platform · JBJS: 791 anatomic total shoulders from Florida Orthopaedic Institute show 96% implant survival at 10 years, but 69.5% of shoulders at the patient-acceptable threshold
DePuy Synthes signs a U.S. sales agency agreement with SMAIO for the KEOPS-4ME planning platform and patient-specific K-ROD rods · FDA grants De Novo to Brixton Biosciences' ReneuRx (Neural Ice), an injectable cold slurry for knee OA pain, creating a new Class II category · Anesthesia & Analgesia RCT, 180 PLIF patients: deep neuromuscular block cut 3-month chronic postsurgical pain from 34.8% to 19.1% versus moderate block; no significant difference at 6 months · J Neurosurg Spine, CSM-Protect secondary analysis: dysphagia after multilevel anterior surgery for cervical myelopathy peaked at 68.6% and was still 36.4% at one year
CMS posts the CJR-X participant list: 2,217 hospitals in a mandatory 90-day hip, knee and ankle bundle starting January 1, 2028 · SurGenTec takes an exclusive license to Allevion Medical's Vantage, a fully disposable lumbar decompression kit cleared in March as K252546 · FDA 510(k) clears Mass General's GSPE Spacer, a gentamicin-loaded UHMWPE temporary knee spacer for two-stage PJI; commercial license still pending · JBJS Yale RCT in primary THA: anterior QLB plus LFCN block vs periarticular/local infiltration, both with dual glucocorticoids, no difference in day-one opioids
Centinel Spine files publicly for a NYSE IPO under CNTL: first-half 2026 revenue $85.2M (+42%), net income $10.2M, pure-play prodisc total disc replacement · MRI2CT announces FDA 510(k) clearance for NextMR Spine, cloud software that generates 3D lumbar spine and sacrum bone images from standard MRI, entering a category MRIguidance's BoneMRI has held since 2022 · Smith+Nephew launches CARTIHEAL AGILI-C in 12 European markets ahead of the ICRS Summit in Porto, on five-year RCT data against microfracture and debridement · KSSTA, Bridge registry two-year results for Miach's BEAR implant: 5.6% ipsilateral ACL retear, none in year one, but 18.9% overall reoperation (28.0% original vs 7.5% modified technique)
icotec's CMORE CT carbon/PEEK cervicothoracic system gets a Medicare new technology add-on payment, up to $60,905 per case, for fusion use only · Stryker names Spencer Stiles CEO effective January 1, 2027; Kevin Lobo becomes Executive Chair · Neurosurgical Focus, pooled analysis of two randomized trials (211 patients): wound dehiscence 0% after biportal endoscopic vs 8.7% after microscopic single-level lumbar decompression
Pacira licenses EXPAREL to Molteni Farmaceutici for the EU and UK; Italy, Germany, Austria and Poland first, first commercial sale expected in 2027 · Spine RCT, 70 patients with grade III-IV spondylolisthesis: extending L4-S1 fixation to S2 or S2AI cut S1 screw breakage from 66% to zero and improved 36-month pain and ODI · Spine, Houston Methodist: screening ligamentum flavum at lumbar decompression found transthyretin amyloid in 20% of 50 selected patients
AMA CPT Editorial Panel votes a Category I code for posterior vertebral column arthroplasty, covering Premia Spine's TOPS facet replacement, effective January 1, 2028 · J Neurosurg Spine, Washington State Spine COAP registry: intrawound antibiotics not associated with fewer surgical site infections across 24,015 instrumented spine cases · CORR target trial emulation of 4,564 Japanese periprosthetic hip fractures: no clear 30- or 90-day mortality difference between surgery within two days and surgery on days three to ten
PearlMatrix P-15 peptide bone graft's Medicare new technology add-on payment goes live October 1 — TLIF use only, capped at $3,380, alongside INFUSE's $4,396.60 TLIF add-on · Tenon Medical takes the 3D-printed titanium lateral screw in its SImmetry+ SI joint fusion system to full commercial launch after a ~$1.2M alpha · JBJS: revision hip and knee volume across 17 registry countries projected to rise ~36% by 2060, led by the US and China · BMJ, UK National Joint Registry target trial emulation: robotic and conventional hips and knees show equal five-year implant survival; robotic hips had about half the malposition-related revisions
Terumo Neuro signs to acquire Arsenal Medical and its investigational NeoCast liquid embolic for middle meningeal artery embolization, now in a pivotal trial head to head against Onyx · Sharp HealthCare becomes a strategic equity partner in the DISC Surgery Center at Carlsbad, a spine-heavy ASC, three months after taking over Tri-City Medical Center · Two rib fixation entrants in one week: Chest Wall Innovations launches PC Fix, with an intrathoracic PEEK option, and GMReis announces 510(k) clearance for VersaLock rib and sternum plates · NEJM publishes TRIUMPH-1: retatrutide cut weight by up to 25% at 80 weeks and reduced WOMAC knee pain 1.6 to 1.8 points more than placebo in 574 participants with knee osteoarthritis
Carlsmed appoints former ZimVie CFO Richard Heppenstall as chief financial officer and reaffirms 2026 revenue guidance of $74 to $78 million ahead of the October 1 aprevo payment policy · VB Spine receives FDA Breakthrough Device Designation for ScolimiR-3D, a six-microRNA blood test to predict adolescent idiopathic scoliosis progression · Anesthesiology: in 258,624 Ontario hip and knee arthroplasties, a new extended-release opioid prescription at discharge was associated with more persistent opioid use, readmissions and ED visits · OTA 2026 randomized trial: local aqueous tobramycin added to IV antibiotics did not reduce infection in 569 open extremity fractures
FDA issues draft guidance on premarket submissions for robotically-assisted surgical devices; orthopedic (OLO) and neurological (HAW) stereotaxic systems are explicitly out of scope; comments due November 24, 2026 · Avesi Partners invests in New Age Medical, a St. Louis spine supply hub linking 85+ manufacturers, 100+ reps, 200+ hospitals/ASCs and 350+ surgeons, to fund expansion, new specialties and M&A · SI-BONE receives FDA 510(k) clearance for iFuse Granite Onyx, aimed at screw loosening at the UIV and LIV of spinal fusion constructs in low-density bone · HSS cohort at EBJIS-MSIS 2026: extended oral antibiotics after two-stage TKA reimplantation did not reduce PJI-related reoperation in 2,181 patients
Spine Journal: in 18,914 matched single-level P/TLIFs, rhBMP-2 added $4,543 and 14% to the index encounter with no significant difference in readmission, revision or two-year costs · Precision Neuroscience closes an oversubscribed $250M Series D for its Layer 7 surface brain-computer interface · UPMC's CLEAR rapid exchange protocol for recalcitrant PJI: 10% failure versus 60% for historical repeat two-stage controls (EBJIS-MSIS 2026) · ICSES 2026 meta-analysis: PRP no better than placebo for lateral epicondylitis across six RCTs and 355 patients
Catalyst OrthoScience joins Redefine Surgery as founding shoulder partner, off an oversubscribed $10M surgeon-backed pre-seed round · SIGNUS USA's COSY occipitocervical-thoracic fixation system completes its first U.S. surgery · SI-BONE recalls 98 iFuse TORQ implants over a sterile-packaging failure, recommends FDA Class II classification
Smith+Nephew clears the LANDMARK Total Knee System and completes its first cases, with a fully 3D-printed CONCELOC femur built around CORI · Enovis becomes the first industry sponsor to fund two AAOS registries at once, adding the Shoulder & Elbow Registry to AJRR through 2027 · Xenix Medical clears the Riva Anchor spinopelvic fixation system with a NanoACTIV surface, going after SI-BONE's hold on the base of long deformity constructs · Clinical Orthopaedics publishes FNF-ON8, a five-variable score for osteonecrosis after femoral neck fracture fixation that outperforms the Garden classification
JBJS: a Houston private practice audits three years of CPT 22-modifier claims — 71.7% approved, 7.7% more money, and up to 77% longer to get paid · ORTHOWORLD's 2026 spine market analysis: an $11B market growing ~3%, with Medtronic and Globus at a combined 43% and nobody else above 8% · Smith+Nephew brings the acquired Tendon Seam cuff system, a new knotless anchor and both-sides handheld shoulder robotics to ICSES 2026 — contesting Zimmer Biomet's May 'first' claim · ESSKA and the European Shoulder Associates publish their formal consensus on partial-thickness posterosuperior cuff tears: nonsurgical first, one Grade A recommendation, and Grade B support for PRP · Five-year randomized subgroup from Lyon: 16.4% graft failure after isolated BPTB versus 4.8% for hamstring plus anterolateral ligament reconstruction in patients under 25
Two bunion datasets out of AOFAS 2026 pull against each other: Treace's five-year ALIGN3D Lapiplasty results, and an HSS series where MIS Lapidus matched open Lapidus on PROMIS at one year · Zimmer Biomet takes the both-sides ROSA Shoulder System to ICSES 2026 in Vancouver, where Stryker and Enovis are the other top-tier sponsors · Fusion Orthopedics launches the FibFix fibula nail into AOFAS and OTA, going after a small intramedullary category held by Acumed and Arthrex · Clinical Orthopaedics and Related Research publishes a methodological audit finding the synovial leukocyte count and differential are poor standalone rule-in tests for PJI, against the 2025 meta-analysis behind the Unified PJI Criteria
Mindray launches the SV70 non-invasive ventilator into the fleet-replacement hole Philips left when it exited hospital ventilation · Stryker brings Prophecy patient-specific planning to the Incompass total ankle, plus a Hoffmann LRF smartHEX frame with a patient-facing app, at AOFAS 2026 · SIGNUS USA completes the first US implantation of COSY, its posterior occipito-cervico-thoracic fixation system, with up to 70 degrees of screw angulation · Onkos releases the ELEOS Total Femoral Adapter with NanoCept, the first implant coated at its own new New Jersey facility, with human infection-reduction data still pending a Section 522 study
CMS expands the ACCESS digital chronic-care model: four new tracks from spring 2027 and musculoskeletal pain support past the first 12 months · Federal Circuit affirms Globus Medical's noninfringement win over three Moskowitz Family spinal implant patents in a precedential opinion · Synergy Spine presents two-year ALIGN-1L IDE data at SMISS: 87.1% composite clinical success for the one-level Synergy Disc versus 56.6% for matched ACDF controls
HHS OIG: Medicare Advantage plans under-screen out-of-network equipment suppliers, who bill seven times more for orthotics than enrolled suppliers · Zimmer Biomet proposes cutting up to 580 jobs at its Winterthur, Switzerland plant — most of the site · Paradromics says the first Connexus BCI participant is using the implant for real-time, self-generated speech · Arthritis Care & Research: fully automated MRI cartilage segmentation separates knees headed for replacement at least as well as expert manual analysis
Bloomberg and WSJ: J&J is in talks to sell DePuy Synthes to Apollo Global Management for close to $20 billion · AAOS files its CY2027 fee schedule comment letter on the deadline: keep 2026 work RVUs for primary hip, knee and shoulder arthroplasty and drop the 50% same-day E/M cut · ACR posts its 2026 osteoarthritis guideline: strong against PRP and stem cell injections in knee and hip, conditional yes to GLP-1 receptor agonists in knee OA with obesity
SI-BONE recalls 98 iFuse TORQ implants over tube packaging that may not hold a sterile barrier; two already implanted · Medtronic's Stealth AXiS does its first clinical cases in Europe, starting with complex spine revision · Mayo Clinic: about 30% of knee MACI biopsies proceed to implantation at a mean 4.3 years
FDA puts its most serious recall classification on Boston Scientific's Infinion CX spinal cord stimulator leads after 1,081 serious injuries · Shoulder Innovations clears the N-22 humeral head for metal-hypersensitive anatomic total shoulder and ships the same day · Shoulder Innovations takes exclusive US upper-extremity rights to ALM Ortho's patient-matched titanium implants · restor3d launches MyFit, a patient-facing layer whose real payload is a 2,250-patient patient-specific implant registry · Biocomposites takes combination-antibiotic STIMULAN biofilm data to EBJIS-MSIS in Porto
Medacta's H1 2026: 9.7% constant-currency growth, but North America is the slowest region and gross margin fell 310 basis points · ArthroTAK's sutureless PEEK anchor clears FDA for expanded indications, and its first target is lateral extra-articular tenodesis · Journal of Spine Surgery publishes cadaveric accuracy data on OnPoint's augmented reality guidance: 1.1 mm positional, 1.3 degrees angular across 80 pedicle screws · Bone Biologics doubles its Australian NB1 sites to six, aiming to finish enrollment in the rhNELL-1 TLIF pilot by year end
AMA and more than 150 organizations ask CMS to withdraw the modifier-25 payment cut before the September 14 comment deadline · AMA backs site-neutral imaging in the CY2027 outpatient rule but objects to $260M leaving Part B with nothing coming back · Kinomatic launches Kinect, an implant-independent planning platform whose real product is the joint-replacement data lake underneath it · Globus Medical takes Excelsius3D into the EU and UK on a CE mark, five years after its FDA clearance
